Pd51-10 Characterizing the Incidence, Predictors, and Survival of Disappearing Renal Tumors From the Dissrm Registry
Year: 2018
Type: article
Study design: Observational Study
Abstract: patients reported high anxiety (7-10), which decreased to 16% at the end of the encounter.Most patients (88%) answered yes when asked if knowledge of cancer diagnosis would help make them make treatment decision and 94% of patients answered yes when asked whether they would consider renal mass biopsy.Following counseling, 43% of surveyed patients received renal mass biopsy.The most common reason given for not obtaining a biopsy was that physician did not believe it would change treatment recommendation.Prior to counseling, patients reported that they would consider treatment options including: 71% active surveillance (AS), 76% thermal ablation (TA), 78% partial nephrectomy (PN), and 39% radical nephrectomy (RN).When patients ranked (1-4) most important factors to consider before treatment, the most common reasons were: risk of cancer spreading or coming back after treatment (75%) and risk of damage to the kidney (25%).Diagnosis (biopsy or surgery) of SRM was RCC in 53, oncocytoma/AML 12, metastatic esophageal cancer and not biopsied in 34.Active surveillance/no treatment was primary management for 48 patients.CONCLUSIONS: A large majority of SRM patients are in favor of pre-treatment biopsy to improve decision making, although less than half of patients received biopsy after counseling.High anxiety is reported by half of SRM patients but decreases following physician visit.
Source: The Journal of Urology
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2796016810